ED90 for Hyperbaric Bupivacaine in Super Obese Parturients

• Status: Recruiting
• Trial end date: 2022-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to determine the ED90 of hyperbaric intrathecal bupivacaine for the super obese population undergoing cesarean section under a combined spinal epidural technique.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Duke University
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• American Society of Anesthesiology (ASA) class 2 and 3

• English speaking

• Gestational age > 36 weeks

• Scheduled for cesarean delivery under combined spinal epidural anesthesia

• 18 years or older

• BMI > 50 kg/m2

Exclusion Criteria:

• History of past or current intravenous drug or chronic opioid abuse

• Allergy or contraindication to any study medications

• Intrapartum cesarean delivery under epidural anesthesia

• Cesarean delivery under general anesthesia